Looking Ahead: NIAID’s Future HIV/AIDS Therapeutics Priorities
By Carl W. Dieffenbach, Ph.D., Director of NIAID's Division of AIDS

Since the 1980s when the HIV/AIDS epidemic was first recognized, NIAID-supported clinical research has helped to save millions of lives and played a key role in defining the standard of care for treating HIV infection. This blog post describes what we are seeking for the next wave of HIV/AIDS therapeutic approaches. Specifically, we have identified the following three research priorities: 1) finding a cure for HIV-infected individuals; 2) developing therapeutic strategies for preventing and treating tuberculosis (TB) and hepatitis C in HIV-infected individuals and individuals at high risk for co- infection; and 3) addressing the long-term consequences of treatment of HIV infection.
Continue reading "Looking Ahead: NIAID’s Future HIV/AIDS Therapeutics Priorities" »






